AIM ImmunoTech to Participate in Webull Financial's Corporate Connect Webinar Series
ByAinvest
Friday, Feb 6, 2026 8:57 am ET1min read
AIM--
BULL--
AIM ImmunoTech will participate in the Corporate Connect Webinar Series hosted by Webull Financial on February 11, 2026. Thomas K. Equels, CEO, will provide a corporate overview and business outlook, focusing on the company's strategic emphasis on pancreatic cancer. The presentation will be live at 1:40 PM EST, and registration can be accessed through the provided link.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet